| Financial Year |
March 31 2023 |
| Monetary Funds |
101,438,999.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
103,392,937.42 |
| Accounts Receivable |
2,030,028,493.85 |
| Advances to Suppliers |
171,224,301.37 |
| Other Receivables |
105,947,208.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
284,416,865.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,522,491.42 |
| Total Current Assets |
2,851,915,085.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,274,212.24 |
| Investment Properties |
16,784,127.86 |
| Fixed Assetes |
146,975,331.06 |
| Under-construction Projects |
66,419,811.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,853,666.70 |
| R&D expenses |
-- |
| Goodwill |
64,129,341.08 |
| Long-Term Deferred and Prepaid Expenses |
3,310,848.85 |
| Deferred Income Tax Assets |
40,993,629.49 |
| Other Non-Current Assets |
8,626,270.51 |
| Sub-Total of Non-Current Assets |
417,987,256.36 |
| Total Assets |
3,269,902,341.91 |
| Short-Term Loans |
567,431,189.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
342,156,331.46 |
| Accounts Received In Advance |
237,587.62 |
| Employee Compensation Payable |
46,333,301.45 |
| Taxes Payable |
40,056,769.26 |
| Interest Payable |
4,540,634.72 |
| Dividend Payable |
-- |
| Other payables |
205,070,035.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,915,337.81 |
| Other Current Liabilities |
69,403,831.11 |
| Sub-Total of Current Liabilities |
1,473,633,539.58 |
| Long-term Loans |
123,365,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,808,701.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
137,393,960.00 |
| Total Liabilities |
1,611,027,499.58 |
| Paid-In Capital(Or Share Stock) |
753,971,950.00 |
| Capital Surplus |
1,301,668,795.90 |
| Surplus Reserve |
10,213,657.36 |
| LESS:Treasury Stock |
1,352,000.00 |
| Undistributed Profits |
-504,444,277.43 |
| Minority Stockholder's Interest |
88,298,207.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,570,576,634.78 |
| Owner's Equity（Stockholder's Equity） |
1,658,874,842.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,269,902,341.91 |
